This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Engaging in creative expression like painting, music,…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Michele Castro’s mother and brother both passed…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Despite being underrepresented in clinical trials, Latinos…
The science behind Alzheimer’s is constantly developing, but its cause remains elusive and the disease is frequently misdiagnosed. A 2017 study at a hospital…
On Friday, October 20th at 10:00 a.m. PT / 1:00 p.m. ET, artist, community advocate, and Atlantic Fellow for Health Equity Gloria Aguirre joins…
Is dementia preventable? Research shows that yes, sometimes, it is. Scientists project that the number of people living with dementia, a neurodegenerative syndrome which…
One day, Don Kent’s personality started changing. A cool, even-keeled lawyer, he found himself suddenly losing control of his emotions. At the same time,…
Living with dementia can present unique challenges for older adults and their loved ones. Incorporating suitable games into their daily routines can have a…
On Friday, September 15th at 12:00 p.m. PT/3:00 p.m. ET, LuPita Gutierrez-Parker will join Being Patient Live Talks to share her experience living with…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Research shows that Black, Latino, and indigenous…
Difficulties with cognitive functions or skills, such as the ability to recall memories, concentrate on tasks, or find the right words in conversation, are…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Dr. Indira Turney was born in the…
This event has passed. You can read highlights from the interview and watch the YouTube recording of the talk here. On Thursday, August 24th, at…
In January of 2023, the Food and Drug Administration approved the second anti-amyloid therapy for Alzheimer’s disease, Leqembi (generic name lecanemab). A new Alzheimer’s…
On Friday, August 11th at 10:00 a.m. PT/1:00 p.m. ET, Alzheimer’s advocate Michele Castro joins Being Patient Live Talks. Castro inherited the PSEN1 genetic…